Subunit Vaccines: Distearoylphosphatidylcholine-Based Liposomes Entrapping Antigen Offer a Neutral Alternative to Dimethyldioctadecylammonium-Based Cationic Liposomes as an Adjuvant Delivery System-Reference-Cited by-同舟云学术

Subunit Vaccines: Distearoylphosphatidylcholine-Based Liposomes Entrapping Antigen Offer a Neutral Alternative to Dimethyldioctadecylammonium-Based Cationic Liposomes as an Adjuvant Delivery System

Published:2011-05 Issue:5 Volume:100 Page:1856-1865
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

McNeil Sarah E.,Rosenkrands Ida,Agger Else Marie,Andersen Peter,Perrie Yvonne

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference42 articles.

1. Liposomes as immunological adjuvants;Allison;Nature,1974

2. Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate) – A novel adjuvant inducing both strong CMI and antibody responses;Davidsen;Biochim Biophys Acta (BBA) – Biomembranes,2005

3. Adjuvants for human vaccines–current status, problems and future prospects;Gupta;Vaccine,1995

4. Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen;Henriksen-Lacey;J Control Release,2010

5. Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response;Henriksen-Lacey;J Control Release,2010

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology Platform for Advancing Vaccine Development against the COVID-19 Virus;Diseases;2023-12-10

2. In vivo evaluation of new adjuvant systems based on combination of Salmonella Typhi porins with particulate systems: Liposomes versus polymeric particles;International Journal of Pharmaceutics;2023-12

3. Liposomal delivery system/adjuvant for tuberculosis vaccine;Immunity, Inflammation and Disease;2023-06

4. Liposomes vs Phytosomes: Principles, Methodologies, and Therapeutic Applications with Emphasis on CNS Disorders;Nanopharmaceuticals: Principles and Applications Vol. 1;2020-07-15

5. Does the Development of Vaccines Advance Solutions for Tuberculosis?;Current Molecular Pharmacology;2019-04-11